CRH, corticotropin releasing hormone, 1392

N. diseases: 402; N. variants: 2
Disease: Neuroendocrine Tumors ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0206754
Disease: Neuroendocrine Tumors
Neuroendocrine Tumors 		0.030 Biomarker group BEFREE Thymic NET with CS exhibited stronger immunoreactivity for ACTH and CRH than those without CS. 30502716 2019
CUI: C0206754
Disease: Neuroendocrine Tumors
Neuroendocrine Tumors 		0.030 AlteredExpression group BEFREE ACTH = adrenocorticotropic hormone; BIPSS = bilateral inferior petrosal sinus sampling; CBG = corticosteroid-binding globulin; CD = Cushing disease; CRH = corticotropin-releasing hormone; CS = Cushing syndrome; Dex = dexamethasone; DST = dexamethasone suppression test; EAS = ectopic ACTH syndrome; FDA = U.S. Food & Drug Administration; HDDST = high-dose DST; IPS/P = inferior petrosal sinus to peripheral; MRI = magnetic resonance imaging; NET = neuroendocrine tumor; PET = positron emission tomography; UFC = urinary free cortisol. 28614036 2017
CUI: C0206754
Disease: Neuroendocrine Tumors
Neuroendocrine Tumors 		0.030 AlteredExpression group BEFREE In contrast with the V3 receptor, CRH receptor mRNA was detected in the majority of neuroendocrine tumors irrespective of their POMC status. 8636444 1996